Market Currents
Seattle Genetics (SGEN -1.1%) CEO Clay Siegall says it's not the right time to sell the company...
-
Friday, July 13, 2012, 11:02 AM ETSeattle Genetics (SGEN -1.1%) CEO Clay Siegall says it's not the right time to sell the company with its pipeline and growth trajectory looking strong. Though it's more than a little speculative that a major buyer would still be interested in an acquisition after shares of SGEN ran up over 52% YTD on the potential for Adcetris, the CEO's bravado still provides guidance on the M&A front.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
